Grant: Discovery Grants Program - Individual
University of Calgary
$100,000.00
Rhinovirus and epithelial biology
EF 2022-23
Résumé
BACKGROUND: Much of our understanding concerning how rhinovirus (RV) replicates, induces host antiviral responses and escapes from cells is based on studies using cell lines not of airway origin. Human airway epithelial cells (HAE) are the natural host for RV infections. Using highly differentiated HAE from normal subjects, we have obtained data that question several aspects of existing dogma on how RV replicates and exerts effects in cells. These findings suggest that cell context is critical and that we must use HAE to understand how RV functions during “real world” infections.OVERALL GOAL: To characterize the control of the replication cycle and shedding of HRV in highly differentiated HAE from normal subjects, and to define key mechanisms regulating epithelial antiviral immunity.HYPOTHESES: 1) that dsRNA differentially regulates RV replication and antiviral gene induction in HAE; 2) that RV is shed from HAE via exosomes.PRELIMINARY OBSERVATIONS: We infected HAE from normal subjects with varying initial infectious doses of RV and found that the kinetics of HRV replication was slower with lower initial doses but that the peak virus loads were similar at all doses. By contrast, expression of the antiviral IFN-lambda depended directly on initial infectious dose, with less IFN-lambda at lower infectious doses. This directly challenges dogma that levels of double-stranded RNA (dsRNA) formed during the virus cycle regulate both viral load and levels of antivirals. Moreover, infected HAE completely cleared RV infections in the absence of immune cells, despite the consensus that immune cells are required. Finally, RV does not cause lysis of HAE, so HRV secretion cannot occur via a lytic mechanism, as dogma has suggested. AIMS: As part of a long-term program to define major steps in RV replication and altered function in normal HAE, our initial aims are 1) to determine if initial infectious dose regulates the numbers of cells infected and the kinetics and levels of dsRNA generated; 2) to determine the relationship between levels of dsRNA, viral replication and production of antivirals; 3 to determine if IFNs regulate production of other antivirals; and 4 determine how RV is released from HAE. EXPERIMENTAL APPROACH: We will address these questions in highly differentiated HAE from normal subjects using methodologies including confocal fluorescent microscopy of labeled RV, as well fluorescence microscopy of markers of membrane vesicles and exosomes, supplemented by electron microscopy. We will use primer specific RT-PCR to quantify dsRNA levels, and will knockdown specific pathways using siRNA. OUTCOMES: The studies described will provide excellent opportunities for the training of HQP. In addition, virologists and immunologists will benefit from critical new mechanistic data to advance our knowledge of the normal regulation of RV replication and innate immune responses in its natural host cell.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-03861
Name nom
Proud, David
Department département
Physiology and Pharmacology - Physiology and Pharmacology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
100000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Rhinovirus and epithelial biology
Application summary
BACKGROUND: Much of our understanding concerning how rhinovirus (RV) replicates, induces host antiviral responses and escapes from cells is based on studies using cell lines not of airway origin. Human airway epithelial cells (HAE) are the natural host for RV infections. Using highly differentiated HAE from normal subjects, we have obtained data that question several aspects of existing dogma on how RV replicates and exerts effects in cells. These findings suggest that cell context is critical and that we must use HAE to understand how RV functions during “real world” infections.OVERALL GOAL: To characterize the control of the replication cycle and shedding of HRV in highly differentiated HAE from normal subjects, and to define key mechanisms regulating epithelial antiviral immunity.HYPOTHESES: 1) that dsRNA differentially regulates RV replication and antiviral gene induction in HAE; 2) that RV is shed from HAE via exosomes.PRELIMINARY OBSERVATIONS: We infected HAE from normal subjects with varying initial infectious doses of RV and found that the kinetics of HRV replication was slower with lower initial doses but that the peak virus loads were similar at all doses. By contrast, expression of the antiviral IFN-lambda depended directly on initial infectious dose, with less IFN-lambda at lower infectious doses. This directly challenges dogma that levels of double-stranded RNA (dsRNA) formed during the virus cycle regulate both viral load and levels of antivirals. Moreover, infected HAE completely cleared RV infections in the absence of immune cells, despite the consensus that immune cells are required. Finally, RV does not cause lysis of HAE, so HRV secretion cannot occur via a lytic mechanism, as dogma has suggested. AIMS: As part of a long-term program to define major steps in RV replication and altered function in normal HAE, our initial aims are 1) to determine if initial infectious dose regulates the numbers of cells infected and the kinetics and levels of dsRNA generated; 2) to determine the relationship between levels of dsRNA, viral replication and production of antivirals; 3 to determine if IFNs regulate production of other antivirals; and 4 determine how RV is released from HAE. EXPERIMENTAL APPROACH: We will address these questions in highly differentiated HAE from normal subjects using methodologies including confocal fluorescent microscopy of labeled RV, as well fluorescence microscopy of markers of membrane vesicles and exosomes, supplemented by electron microscopy. We will use primer specific RT-PCR to quantify dsRNA levels, and will knockdown specific pathways using siRNA. OUTCOMES: The studies described will provide excellent opportunities for the training of HQP. In addition, virologists and immunologists will benefit from critical new mechanistic data to advance our knowledge of the normal regulation of RV replication and innate immune responses in its natural host cell.